| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Care.com and Headspace Launch Mental Health Partnership for Caregivers | ||
| Mo | Gilead Sciences Is Acquiring Arcellx and Partnered Multiple Myeloma Drug in $7.8B Deal | ||
| Mo | Designing Scalable Measurement-Based Care Systems for Expanding Health Care Organizations | ||
| Mo | Prior Authorization Is Broken. CMS's New Rule Shows Why Regulated AI Is the Way Out | ||
| Mo | Why HealthTech Products Fail Clinical Deployment & How To Prevent It | ||
| Mo | The Rural Care Crisis Is an Economic Issue, Not Just a Public Health One | ||
| So | What Experts Say About Hims & Hers' $1.15B Acquisition of Eucalyptus | ||
| So | Why Providers Can't Ignore CMS Audits | ||
| So | Startup Korsana Bio Reveals $175M Raised for a Better Brain-Penetrating Alzheimer's Drug | ||
| So | MedCity Pivot Podcast: Should Testosterone Replacement Therapy Be Less Regulated? | ||
| So | AI is Changing Nursing Education and Raising New Graduate Expectations | ||
| 20.02. | Grail's Galleri Blood Test Falls Short in Large Cancer-Screening Study, Shares Sink 50% | ||
| 20.02. | Rainfall Health Raises $15M to Help Hospitals Navigate New CMS Model | ||
| 20.02. | Proven Methodologies For Ensuring Seamless CRM Migrations In Highly Regulated Environments | ||
| 20.02. | Weaving a Unified Fabric of Care Will Heal the Patient-Provider Relationship | ||
| 20.02. | What Frist Cressey Ventures Will Target With Its $425M Healthcare Fund | ||
| 19.02. | Danaher Drops $10B to Snatch Masimo in Diagnostics Push | ||
| 19.02. | Novartis Commits $100M to Startup With Tech That Brings Peptides to Undruggable Targets | ||
| 19.02. | Sustaining Clinician Independence: Why Simplicity, Not Consolidation, Is Key to Solving the Mental Health Crisis | ||
| 19.02. | Imaging Data Liquidity: The Foundation of Multimodal Medical Intelligence | ||
| 19.02. | Anthropic: It's "Critical" To Bring Company Products to EHR | ||
| 18.02. | Solera Health Launches Behavioral Health Network with Calm and Lyra | ||
| 18.02. | Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug | ||
| 18.02. | Healthcare's AI Obsession Is Missing the Point on Nursing Shortages | ||
| 18.02. | Addressing the 58% Launch Failure Rate: Accelerating Market Access Through Intelligent Decision-Making |